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Abstract
Tricho-dento-osseous syndrome (TDO) TDO in these six families was inherited from a common ancestor.
The observation of a common gene mutation in the North Carolina families suggests that variable expression of a single gene mutation is responsible for the differences in clinical characteristics observed between and within these six families. To date, the only other genetic linkage study for TDO was performed by Rivas et ar in a large Virginia kindred.
Results of this linkage analysis using polymorphic protein markers suggested possible linkage with the ABO, Gc, and Kell blood group loci (for the ABO locus, Zmax=0.70, 0=0.00). However, recent evaluation of genetic polymorphisms located near these loci excluded linkage of TDO in four large North Carolina families (all lod scores <-2.0).8 These results argue against a TDO gene modifying gene(s) genetically linked to the ABO, Gc, or Kell loci. The purpose of this study was to evaluate affected and unaffected subjects from the large Virginia family originally reported by Lichtenstein and Warson' to determine whether the genetic basis for TDO in this kindred is the same DLX3 gene mutation common to the six North Carolina families.
Methods

FAMILY ASCERTAINMENT
We have identified, clinically examined, and sampled six subjects related to the TDO kindred of 169 people originally reported by Lichtenstein and Warson' (fig 1) . Three of these subjects were examined clinically and radiographically as previously described.8 w.. _t one copy of the DLX3 gene which is consistent with TDO being transmitted as an autosomal dominant trait. Only the undeleted 145 bp allele was observed in the three unaffected family members.
Discussion
The present study shows that a common mutation is present in affected TDO subjects from the six North Carolina families previously reported by Price et at and the large Virginia kindred previously reported by Lichtenstein et al. 9 Additionally, the affected subjects from this Virginia kindred have the same haplotype region found in all those with TDO who have been tested to date. This finding suggests all affected subjects from these families inherited the mutant DLX3 allele from a common ancestor.
To date there have been four large populations in the United States identified with TDO. Three of these populations are located in geographical proximity to each other ( fig 5) . The kindred reported by Melnick et al'°is derived from one of the North Carolina kindreds. 8 The results of the present study suggest that the concentration of people with TDO in this geographical region results from a founder effect and that these kindreds share a common ancestry.
Phenotypic diversity that appeared to show familial segregation resulted in the suggestion that TDO has three subtypes. 10 affected subjects were examined radiographically with half of those examined being below the age of 18 years. It is possible with this limited sample and the variable expression of bone changes in TDO families that these changes were present but not observed. The present study clearly shows that members of the Virginia kindred can have increased bone density as has been described for TDO types II and III.
Dysplastic dentin was reported as a unique feature for TDO type II.4 Studies of teeth from the North Carolina families showed that approximately 64% had irregular dentin seen primarily in the region coronal to the pulp."
Thus, dentinal changes appear to be variably expressed in subjects with TDO. It is not known whether dentinal changes seen in affected teeth result from expression of the mutant DLX3 gene or occur secondary to thin enamel and excess attrition. The variability of TDO phenotypes in these families having the same DLX3 gene mutation and sharing a common haplotype for genetic STRP loci surrounding the DLX3 gene argue against the existence of multiple TDO subtypes based on phenotypic variation.
In summary, it appears that the TDO syndrome segregating in these North Carolina and Virginia families has a common origin. All affected subjects share the same DLX3 gene deletion mutation and appear to have inherited the gene "identical by descent" from a common ancestor. The variable clinical phenotype found in these North Carolina and Virginia families suggests that clinical variability is not the result of genetic heterogeneity at the major locus, but may reflect genetic heterogeneity at other epigenetic loci or contributing environmental factors. It is unlikely that modifier genes exist close to the ABO, Gc, or Kell loci, as linkage for TDO to genetic markers in these regions was excluded for the North Carolina families. Subclassification of the TDO syndrome based upon reported clinical phenotypes does not appear consistent with the genetic aetiology of the condition in these families.
